NEVVI Medicare utilization intelligence

← back

ANDERSON, ANNMD NPI 1154492247 Clinician

Pathology · GARDEN CITY, NY

Specialty Pathology — from billed Medicare claims
Trained NEW YORK MEDICAL COLLEGE — medical school, self-reported to CMS
In practice about 44 years since medical school (class of 1982, self-reported to CMS)
Location GARDEN CITY, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 29 codes billed · 160,935 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-02

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
87798 Detection test by nucleic acid for organism, amplified probe technique premiumpremium premiumpremium
87481 Detection test for candida species (yeast), amplified probe technique premiumpremium premiumpremium
87651 Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique premiumpremium premiumpremium
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique premiumpremium premiumpremium
87556 Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique premiumpremium premiumpremium
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique premiumpremium premiumpremium
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique premiumpremium premiumpremium
87086 Bacterial colony count, urine premiumpremium premiumpremium
87563 Detection of mycoplasma genitalium by dna or rna probe premiumpremium premiumpremium
87150 Identification of organisms by genetic analysis, amplified probe technique premiumpremium premiumpremium
87186 Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution premiumpremium premiumpremium
87511 Detection test for gardnerella vaginalis (bacteria), amplified probe technique premiumpremium premiumpremium
87088 Bacterial urine culture premiumpremium premiumpremium
87077 Bacterial culture for aerobic isolates premiumpremium premiumpremium
88112 Cell examination of specimen, selective cellular enhancement technique premiumpremium premiumpremium
G0452 Molecular pathology procedure; physician interpretation and report premiumpremium premiumpremium
88120 Cell examination of urine, manual premiumpremium premiumpremium
87491 Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique premiumpremium premiumpremium
87496 Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique premiumpremium premiumpremium
87532 Detection test by nucleic acid for herpes virus-6, amplified probe technique premiumpremium premiumpremium
87591 Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique premiumpremium premiumpremium
87661 Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique premiumpremium premiumpremium
81162 Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants premiumpremium premiumpremium
81307 Gene analysis (partner and localizer of brca2) full sequence analysis premiumpremium premiumpremium
G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method premiumpremium premiumpremium
87106 Fungal culture, yeast premiumpremium premiumpremium
88305 Pathology examination of tissue using a microscope, intermediate complexity premiumpremium premiumpremium
88344 Special stained specimen slides to examine tissue, each multiplex procedure premiumpremium premiumpremium
88121 Cell examination of urine, computer-assisted premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.